InvestorsHub Logo
Followers 26
Posts 8986
Boards Moderated 0
Alias Born 12/11/2013

Re: Rdunn88 post# 114988

Tuesday, 08/04/2015 5:26:52 PM

Tuesday, August 04, 2015 5:26:52 PM

Post# of 403624
Let's examine Leo's Up-listing PR from June 8th...

To me "near term" developments have to be the last 3 PR's included since it's now 2 months since... Just my opinion...

http://finance.yahoo.com/news/cellceutix-provides-uplist-application-115823200.html

Cellceutix wishes to reiterate its stance that it will not perform a reverse split to meet the higher share price requirement. The Company is of the opinion that a number of near-term pipeline developments will remedy any concern with an uplist on the merits of the continued strong fundamentals of Cellceutix.

Expected developments in the coming weeks and months include the conclusion of the Phase 1 trial of Kevetrin for solid tumors and initiation of mid-stage trials of Kevetrin for solid and liquid tumors; the ongoing Phase 2 trial of Brilacidin-OM for oral mucositis; and the start of the Phase 2 trial of Prurisol for psoriasis. Additionally, Cellceutix is meeting with the U.S. Food and Drug Administration in the upcoming weeks to discuss initiating a Phase 3 trial of Brilacidin for Acute Bacterial Skin and Skin Structure Infections.